Exercise during gestation might affect future fertility

Swine study shows that moderate exercise can affect ovarian cells

2013-03-12

(Press-News.org) Des Moines, IA - A short walk around the barn might improve the future fertility of Yorkshire gilts. According to research presented by Samantha Kaminski, a graduate student at North Dakota State University, swine fetuses showed significant ovarian development after their mothers exercised.

Kaminski and fellow researchers already knew that uterine blood flow could affect blood flow to the ovaries of developing fetuses. To further study the relationship between uterine blood flow and ovary development, Kaminski and fellow researchers designed an experiment to increase blood flow through exercise.

The team selected 15 female pigs and bred them to a boar. They then exercised the pregnant sows between days 40 and 105 of gestation. For exercise, the sows were walked for 30 minutes a day, three times a week. The researchers used this exercise regimen with two generations of pigs.

With the first generation, Kaminski and fellow researchers studied ovaries from neonate piglets, adolescent piglets and gilts at six months of age. They looked at ovarian weight, cell proliferation and types of developing cells to compare how exercise might affect ovarian development.

They found that the effects of exercise seemed to decrease as the female pigs grew. In an analysis of heavier weight neonates, Kaminski saw more cell proliferation in the group from the exercised sows.

The adolescent pigs showed no differences in ovarian weight or overall cell proliferation. Kaminski did find a difference in the types of cells in the ovaries between treatment groups. The pigs from exercised sows had a greater proliferation of cells in the antral healthy follicles. The proliferation of antral healthy follicles has been used in previous studies as an indicator of healthy ooyctes and follicles.

With the second generation, the researchers studied the ovaries from developing fetuses on day 94 of gestation. Though she found no difference in fetal ovarian weight, Kaminiski did see more cell proliferation in the ovaries of fetuses from the exercised sows.

Kaminski acknowledged that it would be impractical to walk individual sows in a production setting. She said the exercise regimen of 30 minutes of exercise three times a week could be compared with any "moderate" amount of movement.

"This would be very similar to what a group house setting would be like for sows," said Kaminski.

Kaminski recommended future studies to determine if cell proliferation is a good indicator of future fertility. She would also like to know why there were not significant differences in ovarian weight or cell proliferation in neonatal and adolescent pigs.

###Kaminski's abstract was titled "Impact of maternal exercise on ovarian development in the pig. The presentation was part of the Graduate Student Competition at the 2013 American Dairy Science Association Midwest Branch / American Society of Animal Science Midwest Section Meeting.

ELSE PRESS RELEASES FROM THIS DATE:

Children who avoid scary situations likelier to have anxiety, Mayo Clinic research finds

2013-03-12

ROCHESTER, Minn. -- Children who avoid situations they find scary are likely to have anxiety a Mayo Clinic study of more than 800 children ages 7 to 18 found. The study published this month in Behavior Therapy presents a new method of measuring avoidance behavior in young children. The researchers developed two eight-question surveys: the Children's Avoidance Measure Parent Report and the Children's Avoidance Measure Self Report. The questionnaires ask details about children's avoidance tendencies, for instance, in addressing parents, "When your child is scared or worried ...

Logging debris gives newly planted Douglas-fir forests a leg-up

2013-03-12

The downed limbs and other woody debris that are inevitable byproducts of timber harvest could be among the most important components of post-harvest landscapes, according to a new study led by the U.S. Forest Service's Pacific Northwest Research Station. Researchers found that retaining moderate levels of logging debris, also known as "slash," helped to both directly and indirectly increase the growth rate of Douglas-fir seedlings replanted after harvest. The findings, which are among the first to speak to the benefits of second-growth logging debris, are published ...

Drug may improve outcomes after heart attack

2013-03-12

SAN FRANCISCO (March 10, 2013) — The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. The REMINDER (Reduction of heart failure morbidity in patients with acute ST-elevation myocardial infarction) trial was a randomized, double-blind trial of 1,012 patients who had a heart attack caused by a complete blockage of one of the heart's arteries. Patients had no signs or ...

Investigational drug reduces heart damage during angioplasty

2013-03-12

SAN FRANCISCO (March 10, 2013) — A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session. More than 1 million coronary angioplasty procedures are performed in the United States each year, at a cost of more than $10 billion. Heart tissue can be damaged during angioplasty, often leading to additional procedures, poor outcomes and higher health care costs. In this trial, researchers compared a single dose of ...

Clot-busting drug as effective as angioplasty

2013-03-12

SAN FRANCISCO (March 10, 2013) — A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. "Drug therapy before transfer is at least as effective as [angioplasty], and an urgent catheterization was avoided in two-thirds of patients," said Frans Van de Werf, MD, PhD, professor of cardiology at University of Leuven, Belgium, and the study's lead investigator. "It gives [clinicians] time to consider other options, such ...

Drug reduces chest pain in patients with diabetes

2013-03-12

SAN FRANCISCO (March 10, 2013) — A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both as first line therapy and as an add-on when symptoms are not relieved with other anti-anginal drugs, including beta-blockers, calcium channel ...

High-dose oral vitamins, minerals do not reduce recurrent cardiac events in heart attack patients

2013-03-12

SAN FRANCISCO (March 10, 2013) — Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. However, the results of one component of the NIH-funded Trial to Assess Chelation Therapy (TACT) study, shows that when combined with active chelation therapy, high-dose vitamins and minerals may provide some additional benefit. The TACT study tested the safety and effectiveness of ...

Digoxin reduces hospital admissions in older patients with chronic heart failure

2013-03-12

SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Researchers reviewed patient outcomes from 1995 in the Digitalis Investigation Group (DIG) trial of 6,800 patients with HFrEF—a condition in which the heart is too weak to pump and patients suffer from breathlessness and fatigue. Patients with HFrEF ...

Clot-busting drug benefits intermediate-risk patients with pulmonary embolism

2013-03-12

SAN FRANCISCO (March 11, 2013) — The clot-busting drug tenecteplase prevents death or circulatory collapse in a subgroup of patients with a blood clot in the lungs and appears to be especially useful in patients younger than 75, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Pulmonary embolism occurs when part of a blood clot in a vein breaks off and travels to the lungs. It is fatal about 10 percent of the time, killing between 60,000 and 100,000 Americans each year. The most common cause of death is progressive ...

Screenings, targeted care reduce heart failure in at-risk patients

2013-03-12

SAN FRANCISCO (March 11, 2013) — For at-risk patients, a simple screening and management program can be effective in preventing heart failure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. The five-year STOP-HF study enrolled asymptomatic patients over 40 years of age with risk factors for heart failure and randomized them into an intervention and a control group. Patients in the intervention group were screened for blood levels of B-type natriuretic peptide (BNP), a hormone that indicates how well the heart ...

LAST 30 PRESS RELEASES:

Early diagnosis of bladder cancer, now conveniently at home

People who are autistic and transgender/gender diverse have poorer health and health care

Gene classifier tests for prostate cancer may influence treatment decisions despite lack of evidence for long-term outcomes

Association of waist circumference with all-cause and cardiovascular mortalities in diabetes from the National Health and Nutrition Examination Survey 2003–2018